Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-05

Clinical Trial Update: Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial assessing a triple drug cocktail for metabolic, endocrine changes and perceived stress in polycystic ovary syndrome (PCOS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Khyber Medical University Peshawar | Conditions: PCOS | Phase 2 | Status: COMPLETED